---
figid: PMC5799771__onc2017334f7
figtitle: CK1Alpha-, 26 S proteasome-dependent turnover of FOXO tumour suppressors
  in RAS-mutant cancer cells
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Danio rerio
- Homo sapiens
pmcid: PMC5799771
filename: onc2017334f7.jpg
figlink: /pmc/articles/PMC5799771/figure/fig7/
number: F7
caption: A model of CK1α-, 26 S proteasome-dependent turnover of FOXO tumour suppressors
  in RAS-mutant cancer cells. Oncogenic RAS, via its downstream PI3K/AKT/mTOR effector
  pathway, increases CK1α protein abundance. Sequential phosphorylation of specific
  serine residues of FOXO3A and FOXO4 tumour suppressors by AKT and CK1α earmark them
  for further modifications, leading to their proteolytic degradation by nuclear proteasomes.
  Oncogenic RAS also drives Nrf1/2-dependent expression of proteasome subunits to
  elevate abundance and activity of the 26 S proteasomes for proteolytic eradication
  of nuclear FOXO3A and FOXO4 from RAS-mutant cancer cells. Blockade of CK1α abundance
  or activity (by RNAi or D4476), or inhibition of 26 S proteasome stabilizes FOXO4
  to induce caspase-dependent apoptosis of RAS-mutant cancer cells.
papertitle: Oncogenic RAS-induced CK1α drives nuclear FOXO proteolysis.
reftext: F Zhang, et al. Oncogene. 2018 Jan 18;37(3):363-376.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9668554
figid_alias: PMC5799771__F7
figtype: Figure
redirect_from: /figures/PMC5799771__F7
ndex: a289124f-decf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5799771__onc2017334f7.html
  '@type': Dataset
  description: A model of CK1α-, 26 S proteasome-dependent turnover of FOXO tumour
    suppressors in RAS-mutant cancer cells. Oncogenic RAS, via its downstream PI3K/AKT/mTOR
    effector pathway, increases CK1α protein abundance. Sequential phosphorylation
    of specific serine residues of FOXO3A and FOXO4 tumour suppressors by AKT and
    CK1α earmark them for further modifications, leading to their proteolytic degradation
    by nuclear proteasomes. Oncogenic RAS also drives Nrf1/2-dependent expression
    of proteasome subunits to elevate abundance and activity of the 26 S proteasomes
    for proteolytic eradication of nuclear FOXO3A and FOXO4 from RAS-mutant cancer
    cells. Blockade of CK1α abundance or activity (by RNAi or D4476), or inhibition
    of 26 S proteasome stabilizes FOXO4 to induce caspase-dependent apoptosis of RAS-mutant
    cancer cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Mtor
  - Tor
  - aurA
  - sick
  - Keap1
  - cnc
  - ewg
  - rab1ab
  - mtor
  - foxo4
  - foxo3a
  - nfe2l2a
  - nrf1
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - KRT10
  - FOXO4
  - FOXO3
  - GABPA
  - NFE2L2
  - NRF1
  - NFE2L1
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - Cancer
---
